Targeting leukaemia by modulating hematopoietic stem cell competitiveness

Project Information

Hemstem

Grant agreement ID: 866548

DOI 10.3030/866548

EC signature date 25 February 2020

Start date 1 January 2021

End date 30 June 2027

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 984 240,00

EU contribution € 1 984 240,00

Coordinated by

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany

Publications

Peer reviewed articles (2)

RNA Therapeutics for Improving CAR T-cell Safety and Efficacy

Author(s): P. Schaible, W. Bethge, C. Lengerke and R. A. Haraszti
Published in: Cancer Research, Issue 2023 Vol. 83 Issue 3, 2023, Page(s) Pages 354-362, ISSN 1538-7445
Publisher: AACR Journals
DOI: 10.1158/0008-5472.can-22-2155

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome

Author(s): Ann-Christin Pecher, Luca Hensen, Reinhild Klein, Rebekka Schairer, Katrin Lutz, Daniel Atar, Christian Seitz, Anna Stanger, Janine Schneider, Christiane Braun, Marina Schmidt, Marius Horger, Antje Bornemann, Christoph Faul, Wolfgang Bethge, Joerg Henes, Claudia Lengerke
Published in: JAMA, Issue Vol. 329 Issue 24, 2023, Page(s) Pages 2154-2162, ISSN 1538-3598
Publisher: JAMA Network Publications
DOI: 10.1001/jama.2023.8753